Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624024 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of AQT90 FLEX TnI and TnT
A clinical trial, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- 1,743
- Enrollment target
NCT02624024: Completed study, sponsored by Radiometer Medical ApS.
NCT02624024 is a clinical trial that has completed, run by Radiometer Medical ApS. The registered enrollment target is 1,743 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02624024 has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- 1,743 participants
- Enrollment target
Study Summary
The AQT90 FLEX Troponin I (TnI) and Troponin T (TnT) Tests are in vitro diagnostic assays intended as an aid in the diagnosis of myocardial infarction (MI) in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX TnI and TnT assays for both whole blood and plasma in the intended use population.
Primary Outcome
Diagnosis of acute myocardial infarction (MI) that a subject was experiencing at the time of the subject's presentation to the ED, as determined by independent adjudication panel and based on the Third Universal Definition of Myocardial Infarction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,743 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-06 |
What the finished NCT02624024 record still lists
NCT02624024 is an observational study that tracks outcomes without assigning an intervention. Its 1,743 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02624024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02624024 about?
NCT02624024 is a clinical study titled "Clinical Performance Evaluation of AQT90 FLEX TnI and TnT". The AQT90 FLEX Troponin I (TnI) and Troponin T (TnT) Tests are in vitro diagnostic assays intended as an aid in the diagnosis of myocardial infarction (MI) in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX TnI and TnT assays...
What is the current status of trial NCT02624024?
This trial is currently completed. The enrollment target is 1,743 participants. The study started on 2016-01. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT02624024?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04712656 · 1,739 participants
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- NCT07183527 · 1,750 participants · NA
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia